Woodside’s support of the Harry Perkins Institute of Medical Research has hit a new milestone with their fundraising for the MACA Ride to Conquer Cancer with contributions now totalling $1 million.
Five years ago, a group of Woodside employees formed a Ride team in the Perkins major fundraising event and rallied colleagues for support.
Since then the team has grown to more than 100 cyclists taking part in the two-day, 200km ride.
At the 2016 Ride, held over the weekend of 15-16 October, Team Woodside announced that they had raised more than $280,000, falling just $30,000 shy of its target.
Woodside has made up the shortfall, taking the total for Team Woodside to over $1 million since the team first started participating in the Ride event back in 2012
Woodside Chief Executive Officer, Peter Coleman, said it was employees who actively championed for Woodside to support the Harry Perkins Institute.
“Woodside employees have a history of community giving, from volunteering to fundraising,” Mr Coleman said.
“Team Woodside’s Ride to Conquer Cancer effort is part of that and I would like to thank everyone for their contribution, dedication and hard work.”
Perkins Director, Professor Peter Leedman, said the hard work and determination of the Woodside team was admirable and commended Woodside’s leadership for backing the philanthropic efforts of their staff.
“Woodside has directly supported cutting-edge cancer research, including funding the work of Woodside Professor Ruth Ganss, who is developing new drugs to improve delivery of anti-cancer chemotherapy and immunotherapies,” Professor Leedman said.
“Perkins relies on public support and our work at the Perkins wouldn’t be possible without the support of companies like Woodside.”
In 2015, inspired by its dedicated group of employees, Woodside established the Woodside Cancer Research Fellowship with a donation to the Perkins of $1 million.